Innoviva, Inc.

Innoviva Inc (NASDAQ:INVA): A Decent Value Stock With an Undervalued Earnings Profile
ChartMill · 20 Oct 2026
Is Innoviva (INVA) Undervalued On Its IDWeek 2026 Antibiotic Data Update?
Simply Wall Street · 20 Oct 2026
Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026
Business Wire · 19 Oct 2026
Innoviva Stock Price Forecast. Should You Buy INVA?
StockInvest.us · 16 Oct 2026
Does Unusual Options Trading Change The Bull Case For Innoviva Stock (INVA)?
Simply Wall Street · 14 Oct 2026
Do Options Traders Know Something About Innoviva Stock We Don't?
TradingView · 12 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.